Skip to search
Skip to main content
Back to Search
Start Over
Cannabidiol (Epidyolex®) for severe behavioral manifestations in patients with tuberous sclerosis complex, mucopolysaccharidosis type III and fragile X syndrome: protocol for a series of randomized, placebo-controlled N-of-1 trials
Authors :
CTM & Statistical consultation Cancer Neurologen Brain TN groep Pasterkamp Müller, A. R. den Hollander, B. van de Ven, P. M. Roes, K. C.B. Geertjens, L. Bruining, H. van Karnebeek, C. D.M. Jansen, F. E. de Wit, M. C.Y. ten Hoopen, L. W. Rietman, A. B. Dierckx, B. Wijburg, F. A. Boot, E. Brands, M. M.G. van Eeghen, A. M. CTM & Statistical consultation Cancer Neurologen Brain TN groep Pasterkamp Müller, A. R. den Hollander, B. van de Ven, P. M. Roes, K. C.B. Geertjens, L. Bruining, H. van Karnebeek, C. D.M. Jansen, F. E. de Wit, M. C.Y. ten Hoopen, L. W. Rietman, A. B. Dierckx, B. Wijburg, F. A. Boot, E. Brands, M. M.G. van Eeghen, A. M.
Publication Year :
2024
Details
Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1450185885
Document Type :
Electronic Resource